Underlying mechanisms preserving coronary basal tone and NO-mediated relaxation in obesity: Involvement of β1 subunit-mediated upregulation of BKCa channels

Atherosclerosis. 2017 Aug:263:227-236. doi: 10.1016/j.atherosclerosis.2017.06.354. Epub 2017 Jun 23.

Abstract

Background and aims: The impact of obesity on vasomotor regulation of coronary arteries and its underlying mechanisms are not completely understood and, in particular, the role of BKCa channels in the NO-mediated coronary vasodilation in obesity remains to be elucidated.

Methods: The effects of selective blockade of BKCa channel was tested on nitric oxide (NO)-mediated vasodilator responses of coronary arteries from lean and obese Zucker rats (LZR and OZR, respectively) by means of simultaneous measurements of intracellular Ca2+ concentration ([Ca2+]i) by Fura-2 fluorescence and tension in endothelium-denuded coronary arteries mounted in microvascular myographs. BKCa channel subunits expression was measured by Western blot.

Results: The selective BKCa channel blocker iberitoxin largely reduced the relaxations and decreases in [Ca2+]i induced by a NO donor in coronary arteries from OZR. Iberitoxin increased to a great extent both basal [Ca2+]i and tone in OZR. The agonist of the voltage-gated L-type calcium channels Bay K8644 induced an increase in [Ca2+]i and tone that was significantly smaller in arteries from OZR, which was restored to control levels in LZR after BKCa channel inhibition. Caffeine- and ryanodine-induced intracellular Ca2+ mobilization and BKCa channel β1 subunit expression were increased in arteries from OZR.

Conclusions: The present study suggests that an enhanced activity of VSM BKCa channels, associated with up-regulation of channel β1 subunit and with a higher intracellular Ca2+ mobilization, contributes to the preserved NO-mediated vasodilatation and basal tone of coronary arteries in obesity.

Keywords: BK(ca) channels; Coronary circulation; Metabolic syndrome; Obesity; Vascular smooth muscle; Vasorelaxation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channel Agonists / pharmacology
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism*
  • Coronary Vessels / physiopathology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits / antagonists & inhibitors
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits / metabolism*
  • Male
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / metabolism
  • Nitric Oxide Donors / pharmacology
  • Obesity / metabolism*
  • Obesity / physiopathology
  • Potassium Channel Blockers / pharmacology
  • Rats, Zucker
  • Time Factors
  • Vasodilation* / drug effects

Substances

  • Calcium Channel Agonists
  • Calcium Channels, L-Type
  • Kcnma1 protein, rat
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
  • Nitric Oxide Donors
  • Potassium Channel Blockers
  • Nitric Oxide
  • Calcium